An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

According to a tweet by Applied DNA Sciences (@BNBX_Corp), the company expects its combined BNB holdings to exceed $17 ...

Mahindra has confirmed the launch of its new all-electric 7-seater SUV, the XEV 9S, on November 27, 2025. The EV is expected ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the-Madison suggest that problems with a key protein that helps ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

A study reveals the secrets behind the rodent’s remarkable ability to live 10 times longer than expected, without cancer or ...

The Welsh Rugby Union (WRU) has announced a landmark decision on the future of elite rugby in Wales, following one of the ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Every modern automobile carries a 17-character vehicle identification number, an alphanumeric string unique to that single ...